> For what I know its sales are only limited by how much they can produce.
You are hinting that if only Novo Nordisk invested more in their production facilities, they could see much larger profits than their already astronomical ones they are seeing today.
Except that if Eli Lilly manages to scale up before them, and everyone can buy tirzepatide instead of semaglutide, then Novo Nordisk's customer base could dry up overnight.
You are hinting that if only Novo Nordisk invested more in their production facilities, they could see much larger profits than their already astronomical ones they are seeing today.
Except that if Eli Lilly manages to scale up before them, and everyone can buy tirzepatide instead of semaglutide, then Novo Nordisk's customer base could dry up overnight.